INCY.NASDAQIncyte CORP

Form 4: Incyte EVP Sells Shares in Pre-Planned Transactions

Sentiment:

Insider Transaction Report


Incyte's EVP, Head of Tech. Operations, Michael James Morrissey, sold a total of 58,331 shares of common stock in pre-planned transactions on December 16 and 17, 2025.

Summary

  • Michael James Morrissey, Executive Vice President and Head of Technical Operations at Incyte Corp (INCY), reported sales of common stock.
  • The transactions occurred on December 16 and 17, 2025, and were executed under a Rule 10b5-1 pre-planned contract.
  • On December 16, 2025, Morrissey sold 833 shares at a price of $97.42 per share and an additional 53,175 shares at $97.29 per share.
  • On December 17, 2025, he sold 4,323 shares at a price of $97.26 per share.
  • A total of 58,331 shares of common stock were sold across these transactions.
  • Following these sales, Morrissey beneficially owns 27,507 shares directly.
  • The remaining 27,507 shares include an aggregate of restricted stock units and earned performance stock units that have not yet vested.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive because the sales were pre-planned under a 10b5-1 plan, which mitigates concerns about opportunistic insider selling. It reflects routine executive liquidity management rather than a negative signal about the company's future.

Positives

  • The sales were conducted under a Rule 10b5-1 plan, indicating they were pre-scheduled and not based on new, non-public information, which generally mitigates concerns about opportunistic insider trading.

Negatives

  • Insider selling, even if pre-planned, can sometimes be perceived by some investors as a lack of confidence, although this is often mitigated by the existence of a 10b5-1 plan.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are a routine aspect of executive compensation and personal financial management in publicly traded companies. These plans allow insiders to sell a predetermined number of shares at a predetermined time or price, helping them manage liquidity while complying with insider trading regulations.

Stakeholder Impact

  • Shareholders may note the insider selling, but the pre-planned nature of the transactions under a 10b5-1 plan typically reduces any negative perception or concern regarding the company's prospects.

Key Dates

DateDescription
12/16/2025Transaction date for sales of 833 and 53,175 shares of Common Stock by Michael James Morrissey.
12/17/2025Transaction date for sale of 4,323 shares of Common Stock by Michael James Morrissey.
12/18/2025Date the Form 4 was signed and filed.

Keywords

Incyte, INCY, Form 4, insider trading, stock sale, executive compensation, Michael James Morrissey, 10b5-1 plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.